Medicine and Dentistry
Biological Marker
100%
Malignant Neoplasm
100%
Targeted Therapy
100%
Malignant Peripheral Nerve Sheath Tumor
100%
Diagnosis
66%
Magnetic Resonance Imaging
66%
Cell Signaling Pathway
66%
Neoplasm
33%
Positron Emission Tomography
33%
Nerve Root
33%
Clinical Trial
33%
Ras Signaling
33%
Population
33%
Molecular Pathology
33%
Combination Therapy
33%
Protein P53
33%
Pelvis
33%
Symptomatic Treatment
33%
Signal Transduction
33%
Neural Crest
33%
Neurofibromatosis Type I
33%
Needle Biopsy
33%
Cohort Effect
33%
Fluorodeoxyglucose F 18
33%
Epidermal Growth Factor Receptor
33%
Histopathology
33%
Ifosfamide
33%
Antineoplastic Activity
33%
Mitogen-Activated Protein Kinase
33%
Tumor Microenvironment
33%
Anthracycline
33%
Mammalian Target of Rapamycin
33%
Soft Tissue Sarcoma
33%
Localized Disease
33%
Spindle Cell Sarcoma
33%
Transduction Mechanism
33%
Chromosome 8
33%
Polyethylene Terephthalate
33%
Diseases
33%
Keyphrases
Aggressive Tumor
100%
Standard of Care
100%
Investigational Agents
100%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
100%
Targeted Therapy
30%
Chemotherapy
20%
Histology
10%
Neural Crest
10%
Antitumor Activity
10%
Magnetic Resonance Imaging
10%
Signaling Pathway
10%
Mammalian Target of Rapamycin (mTOR)
10%
Positron Emission Tomography
10%
Pathologic
10%
Molecular Pathogenesis
10%
Signal Transduction Pathway
10%
Metabolism
10%
Palliation
10%
Pelvis
10%
Neurofibromatosis Type 1 (NF-1)
10%
18F-fluorodeoxyglucose (18F-FDG)
10%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
10%
Combinatorial Approach
10%
Epidemiology
10%
Tumor Microenvironment
10%
Local Control
10%
Ifosfamide
10%
Copy number
10%
Trunk
10%
Molecular Biology
10%
Anthracyclines
10%
Objective Response
10%
Comprehensive Assessment
10%
Diagnostic Performance
10%
Inherited Condition
10%
Magnetic Resonance Imaging Guided
10%
Disease Control Rate
10%
Diagnostic Challenge
10%
Chromosome 8
10%
Localized Disease
10%
Multiple Signals
10%
Ongoing Clinical Trials
10%
Druggable Targets
10%
Medical Needs
10%
Soft Tissue Sarcoma
10%
Multiple Signaling Pathways
10%
Downstaging
10%
Ultrasound-guided Core Needle Biopsy
10%
Nerve Root
10%
Spindle Cell Sarcoma
10%
Polycomb Repressive Complex 2 (PRC2)
10%
Unmet
10%
Specific Survival
10%
Nerve Bundles
10%
Treatment Challenges
10%
Targeted Combination
10%
Anatomic Distribution
10%
Excisional Margins
10%